Two people in Denmark suffered cerebral hemorrhages after receiving the AstraZeneca COVID-19 vaccine, according to several reports.
Two hospital staff received the vaccine less than 14 days before experiencing brain bleeding, Reuters reported. The Danish Medicines Agency confirmed that it had received two “serious reports”, but did not provide further details on the matter.
New York Times reported that one of the patients died and the other, a 30-year-old woman, is seriously ill.
Hill contacted AstraZeneca for comments.
The reports are the latest in a series of media reports of a small number of people suffering from blood clots from AstraZeneca vaccine shots. The news also represents the second death in Denmark after the administration of the British-Swedish vaccine.
Denmark stopped using vaccine on March 11 after a 60-year-old woman died of a blood clot after being shot. Other nations, including Germany, France, Italy, Spain, Ireland and Norway, have blocked their use.
The vaccine has not yet been authorized by the US Food and Drug Administration.
AstraZeneca he said last Sunday that there was no evidence to link the vaccine to blood clots after examining 17 million photos taken across Europe.
European Medicines Agency, the regulatory authority for medicinal products in the European Union, he said on Thursday the fact that the AstraZeneca vaccine is safe and effective to use, but did not rule out a link to blood clots. The agency said it would add a warning to the product about the possibility of side effects.
Reuters noted that some countries have reversed their decisions amid the EMA announcement.
The World Health Organization has recommended that countries continue to use the vaccine, saying the benefits of the vaccine outweigh its risks.